The Asparaginase for Injection Market Segment specifically dedicated to pegylated formulations is currently the most significant area of clinical transition in modern oncology. Pegylation—the process of attaching polyethylene glycol chains to the enzyme—dramatically increases the drug's half-life, allowing for once-every-two-weeks dosing instead of daily injections. This is a...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek